Alta Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Hold |
607
| – | – | 0.11% | 162 |
|
|
2025
Q1 | $385K | Buy |
607
+250
| +70% | +$159K | 0.16% | 125 |
|
|
2024
Q4 | $254K | Buy |
357
+57
| +19% | +$40.6K | 0.16% | 122 |
|
|
2024
Q3 | $315K | Hold |
300
| – | – | 0.14% | 84 |
|
|
2024
Q2 | $315K | Hold |
300
| – | – | 0.15% | 80 |
|
|
2024
Q1 | $289K | Hold |
300
| – | – | 0.14% | 88 |
|
|
2023
Q4 | $263K | Hold |
300
| – | – | 0.14% | 90 |
|
|
2023
Q3 | $247K | Hold |
300
| – | – | 0.14% | 84 |
|
|
2023
Q2 | $216K | Hold |
300
| – | – | 0.12% | 100 |
|
|
2023
Q1 | $247K | Hold |
300
| – | – | 0.15% | 86 |
|
|
2022
Q4 | $216K | Hold |
300
| – | – | 0.13% | 94 |
|
|
2022
Q3 | $207K | Buy |
+300
| New | +$207K | 0.13% | 84 |
|